Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?

S Afr Med J. 2020 Jun 2;110(7):572-573. doi: 10.7196/SAMJ.2020.v110i7.14917.

Authors

V Chibabhai¹, A G Duse, O Perovic, G A Richards

Affiliation

¹ Department of Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Clinical Microbiology Laboratory, Charlotte Maxeke Johannesburg Academic Hospital, National Health Laboratory Service, Johannesburg, South Africa. vindana.chibabhai@nhls.ac.za.

PMID: 32880323
DOI: 10.7196/SAMJ.2020.v110i7.14917

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anti-Bacterial Agents
Antimicrobial Stewardship*
Betacoronavirus
COVID-19
China
Coronavirus Infections*
Coronavirus*
Drug Resistance, Bacterial
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2

Substances

Anti-Bacterial Agents